Stop and restart times for blocks and catheters. Works offline once opened.
Anticoagulation appStop and restart times for blocks and catheters. Works offline once opened.
Android (Chrome): tap Install the app, or open the ⋮ menu and choose Install app / Add to Home screen.
iPhone or iPad (Safari): tap the Share button, then Add to Home Screen.
Computer (Chrome or Edge): click the install icon at the right of the address bar.
It opens like an app with its own icon. Once opened with internet, it keeps working with no signal.
Minimum time intervals from the joint ESAIC/ESRA guideline (2022) for neuraxial procedures and deep, non-compressible blocks. The same intervals apply to removing a catheter. "Low dose" means prophylactic and "high dose" means therapeutic. CrCl is creatinine clearance.
Superficial, compressible blocks: may be done while the patient takes anticoagulant or antiplatelet drugs, after weighing the risks; these intervals do not apply.
Deep, non-compressible blocks follow the same intervals as neuraxial procedures. The guideline's Table 2 sorts each block into deep or superficial. Depth from the skin is not the test: it is whether bleeding could be seen and compressed. Check Table 2, and local policy, for the planned block.
The same intervals apply to removing a catheter as to inserting a needle.
If the patient takes two drugs, use the longer interval.
Ultrasound guidance and bleeding-risk scores do not shorten the intervals.
After a bloody tap, consider delaying the next dose.
Reversal: prothrombin complex concentrate and vitamin K 10 mg for warfarin; idarucizumab for dabigatran; protamine for unfractionated heparin.
Antiplatelet drugs
Drug
Last dose → needle or catheter removal
Needle or catheter removal → next dose
Aspirin, low dose (up to 200 mg/day)
No interval needed, after a risk–benefit check. A single-shot spinal is preferred to an epidural.
Routine time
Aspirin, high dose
3 days (normal platelet count) to 7 days
6 h
Clopidogrel
5–7 days
75 mg: without delay. 300 mg loading: 2 days. Not while a catheter is in place.
Prasugrel
7 days
24 h. Not while a catheter is in place.
Ticagrelor
5 days
24 h. Not while a catheter is in place.
Heparins and fondaparinux
Drug
Last dose → needle or catheter removal
Needle or catheter removal → next dose
Unfractionated heparin, prophylactic SC
4 h
Routine prophylaxis time
Unfractionated heparin, therapeutic
IV: 6 h. SC: 12 h. And aPTT, anti-Xa or ACT in the normal range.
Therapeutic dose only after the catheter is out; low-dose heparin meanwhile.
LMWH, prophylactic (e.g. enoxaparin 40 mg once daily)
The American Society of Regional Anesthesia and Pain Medicine (ASRA) guideline, fifth edition (2025): Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy. Timings apply to neuraxial and deep plexus or deep peripheral blocks, and to removing a catheter. "Low dose" means prophylactic and "high dose" means therapeutic. CrCl is creatinine clearance.
Deep plexus and deep peripheral blocks (for example lumbar plexus, paravertebral, infraclavicular, stellate ganglion) follow the same timings as neuraxial blocks.
Other peripheral blocks: decide on how easily the site can be compressed, how vascular it is and what bleeding there would mean.
"After" times run from needle placement or catheter removal, whichever is later. If a DOAC dose is given by mistake while a catheter is in, wait the full "before" time (or check a drug level) before removing it.
A bloody tap does not mean cancelling surgery, but discuss with the surgeon; for LMWH, delay the first dose by 24 h.
Do not use DOAC reversal drugs just to allow a routine block.
Antiplatelet drugs
Drug
Last dose → block or catheter removal
Block or catheter removal → next dose
Aspirin and other NSAIDs
No interval needed
No specific timing
Clopidogrel
5–7 days
Straight away if no loading dose; 6 h after catheter removal if a loading dose is given. A catheter may stay in 1–2 days if no loading dose.
Prasugrel
7–10 days
Straight away if no loading dose; 6 h after catheter removal if a loading dose is given. No catheter while on prasugrel.
Ticagrelor
5 days
Straight away if no loading dose; 6 h after catheter removal if a loading dose is given. No catheter while on ticagrelor.
Cilostazol
2 days
6 h after catheter removal (remove the catheter first)
Cangrelor (IV)
3 h
8 h after catheter removal (remove the catheter first)
Abciximab / eptifibatide, tirofiban
Until platelet function recovers: 24–48 h / 4–8 h
Contraindicated within 4 weeks of surgery
Unfractionated heparin
Drug
Last dose → block or catheter removal
Block or catheter removal → next dose
Low dose SC (5000 U two or three times a day)
4–6 h, or normal coagulation tests
Straight away after catheter removal (remove 4–6 h after a dose). A catheter may stay in.
Higher dose SC (7500–10 000 U twice a day, up to 20 000 U/day)
12 h and normal coagulation tests
Weigh catheter risks case by case
Above 10 000 U a dose or above 20 000 U/day SC
24 h and normal coagulation tests
Weigh catheter risks case by case
IV infusion
4–6 h and normal coagulation tests
1 h after needle placement or catheter removal (remove 4–6 h after the last dose)
Low molecular weight heparin (LMWH)
Drug
Last dose → block or catheter removal
Block or catheter removal → next dose
Low dose (prophylactic)
12 h (check anti-Xa ≤0.1 IU/mL if sooner)
Once daily: first dose 12 h or more after the block; catheter out 12 h after a dose, next dose 4 h later. Twice daily: first dose the next day, at least 12 h after; remove the catheter before starting, next dose 4 h after removal.
High dose (therapeutic)
24 h (anti-Xa ≤0.1 IU/mL, especially if over 75 years or CrCl ≤30)
24 h after the block, or 48–72 h after high-bleeding-risk surgery. Catheter out at least 4 h before the first dose.
Fondaparinux
Drug
Last dose → block or catheter removal
Block or catheter removal → next dose
Low dose (2.5 mg/day)
36 h (younger) to 42 h (elderly); 58 h if CrCl 30–50; avoid if CrCl below 30
Catheter out at least 6 h before the first dose
High dose (5–10 mg/day)
70 h (younger), 105 h (elderly); or calibrated anti-Xa ≤0.1 IU/mL
Catheter out at least 6 h before the first dose
Warfarin
Drug
Last dose → block or catheter removal
Block or catheter removal → next dose
Warfarin
5 days and normal INR
Remove a catheter when INR is below 1.5. Neurological checks for 48 h after removal.
Direct oral anticoagulants (low dose = prophylactic, high dose = therapeutic)
Drug
Last dose → block or catheter removal
Block or catheter removal → next dose
Apixaban
Low dose: 36 h. High dose: 72 h. Or drug level below 30 ng/mL (or anti-Xa ≤0.1 IU/mL).
Low dose: 6 h. High dose: 24 h.
Rivaroxaban
Low dose: 24 h (30 h if CrCl below 30). High dose: 72 h. Or drug level below 30 ng/mL (or anti-Xa ≤0.1 IU/mL).
Low dose: 6 h. High dose: 24 h.
Edoxaban
High dose: 72 h, or drug level below 30 ng/mL (or anti-Xa ≤0.1 IU/mL). No approved low dose.
24 h
Dabigatran
Low dose: 48 h. High dose: 72 h (120 h if CrCl 30–49). If CrCl below 30: only with a level below 30 ng/mL.
Low dose: 6 h. High dose: 24 h.
Other drugs
Drug
Last dose → block or catheter removal
Block or catheter removal → next dose
Argatroban, bivalirudin, desirudin
Neuraxial techniques not advised
Not stated
Thrombolytics (alteplase etc.)
At least 48 h, with normal clotting tests including fibrinogen
Avoid thrombolytics for 10 days after puncture of a non-compressible vessel
Shown in English, exactly as published: the licence does not allow the guideline to be changed or translated.
The UK guideline from the Association of Anaesthetists of Great Britain and Ireland (AAGBI), the Obstetric Anaesthetists' Association and Regional Anaesthesia UK (2013): Regional anaesthesia and patients with abnormalities of coagulation. Table 1 of the UK guideline. Recommended minimum times are based in most circumstances on time to peak drug effect + (elimination half-life × 2), after which time < ¼ of the peak drug level will be present. For those drugs whose actions are unrelated to plasma levels, this calculation is not relevant. These recommendations relate primarily to neuraxial blocks and to patients with normal renal function except where indicated.
Heparins
Drug
Time to peak effect
Elimination half-life
Acceptable time after drug for block performance
Administration of drug while spinal or epidural catheter in place1
Acceptable time after block performance or catheter removal for next drug dose
UFH sc prophylaxis
< 30 min
1–2 h
4 h or normal APTTR
Caution
1 h
UFH iv treatment
< 5 min
1–2 h
4 h or normal APTTR
Caution2
4 h
LMWH sc prophylaxis
3–4 h
3–7 h
12 h
Caution3
4 h3
LMWH sc treatment
3–4 h
3–7 h
24 h
Not recommended
4 h4
Heparin alternatives
Drug
Time to peak effect
Elimination half-life
Acceptable time after drug for block performance
Administration of drug while spinal or epidural catheter in place1
Acceptable time after block performance or catheter removal for next drug dose
Danaparoid prophylaxis
4–5 h
24 h
Avoid (consider anti-Xa levels)
Not recommended
6 h
Danaparoid treatment
4–5 h
24 h
Avoid (consider anti-Xa levels)
Not recommended
6 h
Bivalirudin
5 min
25 min
10 h or normal APTTR
Not recommended
6 h
Argatroban
< 30 min
30–35 min
4 h or normal APTTR
Not recommended
6 h
Fondaparinux prophylaxis5
1–2 h
17–20 h
36–42 h (consider anti-Xa levels)
Not recommended
6–12 h
Fondaparinux treatment5
1–2 h
17–20 h
Avoid (consider anti-Xa levels)
Not recommended
12 h
Antiplatelet drugs
Drug
Time to peak effect
Elimination half-life
Acceptable time after drug for block performance
Administration of drug while spinal or epidural catheter in place1
Acceptable time after block performance or catheter removal for next drug dose
NSAIDs
1–12 h
1–12 h
No additional precautions
No additional precautions
No additional precautions
Aspirin
12–24 h
Not relevant; irreversible effect
No additional precautions
No additional precautions
No additional precautions
Clopidogrel
12–24 h
Not relevant; irreversible effect
7 days
Not recommended
6 h
Prasugrel
15–30 min
Not relevant; irreversible effect
7 days
Not recommended
6 h
Ticagrelor
2 h
8–12 h
5 days
Not recommended
6 h
Tirofiban
< 5 min
4–8 h6
8 h
Not recommended
6 h
Eptifibatide
< 5 min
4–8 h6
8 h
Not recommended
6 h
Abciximab
< 5 min
24–48 h6
48 h
Not recommended
6 h
Dipyridamole
75 min
10 h
No additional precautions
No additional precautions
6 h
Oral anticoagulants
Drug
Time to peak effect
Elimination half-life
Acceptable time after drug for block performance
Administration of drug while spinal or epidural catheter in place1
Acceptable time after block performance or catheter removal for next drug dose
Warfarin
3–5 days
4–5 days
INR ≤ 1.4
Not recommended
After catheter removal
Rivaroxaban prophylaxis5 (CrCl > 30 ml.min−1)
3 h
7–9 h
18 h
Not recommended
6 h
Rivaroxaban treatment5 (CrCl > 30 ml.min−1)
3 h
7–11 h
48 h
Not recommended
6 h
Dabigatran prophylaxis or treatment7 (CrCl > 80 ml.min−1)
0.5–2.0 h
12–17 h
48 h
Not recommended
6 h
Dabigatran (CrCl 50–80 ml.min−1)
0.5–2.0 h
15 h
72 h
Not recommended
6 h
Dabigatran (CrCl 30–50 ml.min−1)
0.5–2.0 h
18 h
96 h
Not recommended
6 h
Apixaban prophylaxis
3–4 h
12 h
24–48 h
Not recommended
6 h
Thrombolytic drugs
Drug
Time to peak effect
Elimination half-life
Acceptable time after drug for block performance
Administration of drug while spinal or epidural catheter in place1
Acceptable time after block performance or catheter removal for next drug dose
Alteplase, anistreplase, reteplase, streptokinase
< 5 min
4–24 min
10 days
Not recommended
10 days
UFH, unfractionated heparin; sc, subcutaneous; APTTR, activated partial thromboplastin time ratio; iv, intravenous; LMWH, low molecular weight heparin; NSAIDs, non-steroidal anti-inflammatory drugs; INR, international normalised ratio; CrCl, creatinine clearance.
Notes to accompany Table 1
The dangers associated with the administration of any drug that affects coagulation while a spinal or epidural catheter is in place should be considered carefully. There are limited data on the safety of the use of the newer drugs in this Table, and they are therefore not recommended until further data become available. The administration of those drugs whose entry in this column is marked as ‘caution’ may be acceptable, but the decision must be based on an evaluation of the risks and benefits of administration. If these drugs are given, the times identified in the column to the left (‘Acceptable time after drug for block performance’) should be used as a guide to the minimum time that should be allowed between drug administration and catheter removal.
It is common for intravenous unfractionated heparin to be given a short time after spinal blockade or insertion of an epidural catheter during vascular and cardiac surgery. Local clinical governance guidelines should be followed and a high index of suspicion should be maintained if any signs attributable to vertebral canal haematoma develop.
Low molecular weight heparins are commonly given in prophylactic doses twice daily after surgery, but many clinicians recommend that only one dose be given in the first 24 h after neuraxial blockade has been performed.
Consider increasing to 24 h if block performance is traumatic.
Manufacturer recommends caution with use of neuraxial catheters.
Time to normal platelet function rather than elimination half-life.
Manufacturer recommends that neuraxial catheters are not used.
Table 2: relative risk related to neuraxial and peripheral nerve blocks in patients with abnormalities of coagulation
Ilio-inguinal block; Ilio-hypogastric block; Transversus abdominis plane block; Fascia lata block
Superficial blocks
Forearm nerve blocks; Saphenous nerve block at the knee; Nerve blocks at the ankle; Superficial cervical plexus block; Wrist block; Digital nerve block; Bier's block